MedImmune to Buy Amgen Colorado Facility?

Quote
















































Great guy but not the one you want leading. Ask him specific questions. He never answers them. Working at LC is too big of a risk as there are better options. d-mab won't even be approved until almost 2018. It's too far behind to warrant the plant running for long.
 


















That guy is terrible. He used to sit at the window and time how long people were gone for lunch. He sent many names to HR. Didn't know he liked to check out the girls. Typical.
 


















anonymous said:
Lose ground? I'd say we already lost.
Click to expand...
Medi has an incredible IO pipeline as well as the huge AZ marketed drugs and pipeline. Yes, they may have lost the race for the CTL4,, PD-1, PDL-1 inhibitors,, but it is the ability to create novel IO as well as combos with their other oncology assets that will put them in first. Let hope the idiots at the top remain patient.
 






AZ is all but acquired and Medimmune all but sold. The financial targets stated are crazy. It's not the idiots at the top, it's the competition and shareholders you have to be worried about. AZ and all assets will be dissolved for profit taking by a bigger fish. If AZ had so much promise they wouldn't have to run from acquisition.
 






anonymous said:
AZ is all but acquired and Medimmune all but sold. The financial targets stated are crazy. It's not the idiots at the top, it's the competition and shareholders you have to be worried about. AZ and all assets will be dissolved for profit taking by a bigger fish. If AZ had so much promise they wouldn't have to run from acquisition.
Click to expand...
AZ to be acquired? Pfizer and other American companies will stay away due to Tax Inversion problems. With Brexit potentially leading to a recession in Europe, don't look for European countries to come to the rescue. The thing that seems logical is that there will be a renewed interest for AZ and GSK to merge to maintain a strong presence in pharma for Britain.
 






AZ was almost purchased a year or so ago. Check the news. That's what led to the ridiculous projections. And while Medimmune has a pipeline I wouldn't say it's very strong. The biggest thing we have is a drug that is years behind in a market that BMS owns. The layoffs are only getting started. But you can live in a dreamland if it helps.
 






anonymous said:
AZ was almost purchased a year or so ago. Check the news. That's what led to the ridiculous projections. And while Medimmune has a pipeline I wouldn't say it's very strong. The biggest thing we have is a drug that is years behind in a market that BMS owns. The layoffs are only getting started. But you can live in a dreamland if it helps.
Click to expand...
Uhh, no kidding that AZ was ALMOST purchased but the tax inversion situation did not sit well for congress thus the passage of new tax laws. Soriot is just bumping up the price for any new suitors.
 






I hear working at the Boulder plant is just like working at Amgen again. Peg has everyone looking for the knife in the back. I was thinking of applying but am concerned with that report and the drug being over estimated. The situation didn't sound too good to leave for. Any other opinions?
 






Top Bottom
Back
Quote